Table 3 The antimicrobial resistance pattern and the presence of resistance genes in different resistance phenotypes
Different phenotypes | No. (%) of isolates with different resistance pattern against | No. (%) of isolates containing | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Azithromycin | Clarithromycin | Quinupristin-dalfopristin | ermB | erm-TR | mefA/E | |||||||
Resistant | Intermediate resistant | Susceptible | Resistant | Intermediate resistant | Susceptible | Resistant | Intermediate resistant | Susceptible | ||||
cMLSB (n = 42) | 25 (59.52) | 9 (21.42) | 8 (19.04) | 24 (57.14) | 6 (14.28) | 12 (28.57) | 30 (71.42) | 8 (19.04) | 4 (9.52) | 41 (97.61) | 19 (45.23) | 4 (9.52) |
iMLSB (n = 15) | 12 (80) | 1 (7.69) | 2 (15.38) | 14 (93.33) | 1 (7.69) | 0 | 8 (53.33) | 5 (38.46) | 2 (15.38) | 15 (100) | 2 (13.33) | 0 |
M (n = 15) | 8 (61.53) | 5 (33.33) | 2 (15.38) | 8 (61.53) | 1 (7.69) | 6 (40) | 8 (61.53) | 5 (38.46) | 2 (15.38) | 15 (100) | 6 (46.15) | 2 (13.33) |
L (n = 7) | 2 (28.57) | 1 (14.28) | 4 (57.14) | 2 (28.57) | 2 (28.57) | 3 (42.85) | 5 (71.42) | 0 | 2 (28.57) | 7 (100) | 3 (42.85) | 2 (28.57) |